Wikidata entity: Q408535
C₂₁H₂₅N₃O₂S (P274)
Quantities
| P4250 | defined daily dose | 0.4 |
| P2067 | mass | 383.166748 |
| P3780 | active ingredient in | ... | Q47522055 (Seroquel) | Seroquel |
| P233 | canonical SMILES | String | C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42 | ??? |
| P373 | Commons category | String | Quetiapine | ??? |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q682 (sulfur) | sulfur |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q12135 (mental disorder) | mental disorder |
| P2175 | medical condition treated | ... | Q38404 (autism) | autism |
| P2175 | medical condition treated | ... | Q11081 (Alzheimer's disease) | Alzheimer's disease |
| P2175 | medical condition treated | ... | Q83030 (dementia) | dementia |
| P2175 | medical condition treated | ... | Q131755 (bipolar disorder) | bipolar disorder |
| P2175 | medical condition treated | ... | Q154430 (anxiety) | anxiety |
| P2175 | medical condition treated | ... | Q170082 (psychosis) | psychosis |
| P2175 | medical condition treated | ... | Q188638 (mood disorder) | mood disorder |
| P2175 | medical condition treated | ... | Q178190 (obsessive-compulsive disorder) | obsessive-compulsive disorder |
| P2175 | medical condition treated | ... | Q202387 (post-traumatic stress disorder) | post-traumatic stress disorder |
| P2175 | medical condition treated | ... | Q208166 (borderline personality disorder) | borderline personality disorder |
| P2175 | medical condition treated | ... | Q270673 (personality disorder) | personality disorder |
| P2175 | medical condition treated | ... | Q544006 (anxiety disorder) | anxiety disorder |
| P2175 | medical condition treated | ... | Q845224 (generalized anxiety disorder) | generalized anxiety disorder |
| P2175 | medical condition treated | ... | Q1869874 (insomnia) | insomnia |
| P2175 | medical condition treated | ... | Q834047 (schizoaffective disorder) | schizoaffective disorder |
| P2175 | medical condition treated | ... | Q2157462 (schizophreniform disorder) | schizophreniform disorder |
| P2175 | medical condition treated | ... | Q3184856 (substance abuse) | substance abuse |
| P2175 | medical condition treated | ... | Q54972453 (sleep-wake disorder) | sleep-wake disorder |
| P361 | part of | ... | Q22274451 (response to quetiapine) | response to quetiapine |
| P129 | physically interacts with | ... | Q309513 (Histamine receptor H1) | Histamine receptor H1 |
| P129 | physically interacts with | ... | Q1949517 (5-hydroxytryptamine receptor 2A) | 5-hydroxytryptamine receptor 2A |
| P129 | physically interacts with | ... | Q2034004 (Dopamine receptor D2) | Dopamine receptor D2 |
| P129 | physically interacts with | ... | Q7050954 (Solute carrier family 6 member 2) | Solute carrier family 6 member 2 |
| P129 | physically interacts with | ... | Q21115043 (5-hydroxytryptamine receptor 1A) | 5-hydroxytryptamine receptor 1A |
| P129 | physically interacts with | ... | Q21115046 (5-hydroxytryptamine receptor 1D) | 5-hydroxytryptamine receptor 1D |
| P129 | physically interacts with | ... | Q21115051 (5-hydroxytryptamine receptor 1E) | 5-hydroxytryptamine receptor 1E |
| P129 | physically interacts with | ... | Q21115052 (5-hydroxytryptamine receptor 1F) | 5-hydroxytryptamine receptor 1F |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q201872 (olanzapine) | olanzapine |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q269111 (apomorphine) | apomorphine |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q411188 (aripiprazole) | aripiprazole |
| P769 | significant drug interaction | ... | Q411229 (itraconazole) | itraconazole |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q417204 (levomepromazine) | levomepromazine |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q412443 (risperidone) | risperidone |
| P769 | significant drug interaction | ... | Q422618 (ritonavir) | ritonavir |
| P769 | significant drug interaction | ... | Q422970 ((±)-promethazine) | (±)-promethazine |
| P769 | significant drug interaction | ... | Q423292 (paliperidone) | paliperidone |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q906453 (posaconazole) | posaconazole |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q5473363 (fosphenytoin) | fosphenytoin |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P9989 | stylized name | String | QUEtiapine | ??? |
| P9989 | stylized name | String | SEROquel | ??? |
| P279 | subclass of | ... | Q156 (alcohols) | alcohols |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P279 | subclass of | ... | Q758295 (atypical antipsychotic) | atypical antipsychotic |
| P2868 | subject has role | ... | Q1328275 (H1 antagonist) | H1 antagonist |
| P2868 | subject has role | ... | Q1927838 (alpha blocker) | alpha blocker |
| P2868 | subject has role | ... | Q3271533 (dopamine antagonist) | dopamine antagonist |
| P2868 | subject has role | ... | Q7455047 (serotonin antagonist) | serotonin antagonist |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | quetiapine | ??? |
Why not click here or view trends?
log id: 1637817